Product methodology
Enforcement Watch
Source contract, normalization path, entity-graph join, refresh posture, and publication limits for this Branmoor product.
Status
In service. This product has a functional preview or paid engagement surface in the current site. The full licensed product may still include private exports, alerts, APIs, or buyer-specific diligence that are not exposed publicly.
Distribution Scope
Nationwide; TN AG/TDH/OIG slice; Nashville provider enforcement view
Product Question
Joins healthcare enforcement actions to providers and owners.
Primary Sources
- HHS OIG advisory opinions and CIAs — Federal compliance precedent and consent agreements
- DOJ healthcare press releases and settlement filings — Resolved and pending healthcare fraud actions
- PACER False Claims Act unsealings — Qui tam cases as they unseal
- CMS survey deficiency database — Hospital, nursing home, and home health survey findings
- State attorney general healthcare action publications — State-level enforcement
- HHS OCR breach portal — HIPAA breach notifications
Entity-Graph Join
`npi`, `ccn`, `irs_ein`, case/docket IDs, parent `edgar_cik`.
Publication Rule
Branmoor does not treat raw public records as the product. A surface is publishable only when the source record is dated, normalized, source-linked, and joined to the relevant Branmoor entity identifiers with enough confidence to state the limits of the result.
Current Methodology Note
The preview register is built on the HHS OIG LEIE (List of Excluded Individuals/Entities) — the canonical federal register of providers excluded from Medicare, Medicaid, and other federal healthcare programs. The licensed Enforcement Watch layer adds OIG Corporate Integrity Agreements, DOJ healthcare-fraud press releases, state Medicaid exclusion lists, CMS provider enrollment revocations, and OCR breach notifications.
Limits
Coverage follows the underlying source. Missing state portals, gated APIs, PDF-only filings, suppressed fields, lagged agency refreshes, and entity-name ambiguity can all limit product completeness. Pending products are not marketed as live until those limits are documented on the product surface.